{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:41:05Z","timestamp":1788932465737,"version":"build-2803163510"},"reference-count":31,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN 225116"],"award-info":[{"award-number":["IN 225116"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.2478\/s11686-019-00125-w","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T14:11:20Z","timestamp":1569852680000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GK1 Improves the Immune Response Induced by Dendritic Cells of BALB\/c Mice Infected with Leishmania mexicana Promastigotes"],"prefix":"10.2478","volume":"65","author":[{"given":"Laila","family":"Guti\u00e9rrez-Kobeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo A.","family":"Wilkins-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"125_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, Team WHOLC (2012) Leishmaniasis worldwide and global estimates of its incidence. PloS One 7:e35671. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PloS One"},{"key":"125_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/qjmed\/hct116","volume":"107","author":"BS McGwire","year":"2014","unstructured":"McGwire BS, Satoskar AR (2014) Leishmaniasis: clinical syndromes and treatment. QJM Int J Med 107:7\u201314. \nhttps:\/\/doi.org\/10.1093\/qjmed\/hct116","journal-title":"QJM Int J Med"},{"key":"125_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","volume":"9","author":"RM Steinman","year":"1991","unstructured":"Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271\u2013296. \nhttps:\/\/doi.org\/10.1146\/annurev.iy.09.040191.001415","journal-title":"Annu Rev Immunol"},{"key":"125_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767\u2013811. \nhttps:\/\/doi.org\/10.1146\/annurev.immunol.18.1.767","journal-title":"Annu Rev Immunol"},{"key":"125_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","volume":"106","author":"A Lanzavecchia","year":"2001","unstructured":"Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106:263\u2013266. \nhttps:\/\/doi.org\/10.1016\/S0092-8674(01)00455-X","journal-title":"Cell"},{"key":"125_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.coi.2013.05.001","volume":"25","author":"K Palucka","year":"2013","unstructured":"Palucka K, Banchereau J (2013) Human dendritic cell subsets in vaccination. Curr Opin Immunol 25:396\u2013402. \nhttps:\/\/doi.org\/10.1016\/j.coi.2013.05.001","journal-title":"Curr Opin Immunol"},{"key":"125_CR7","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/cti.2014.4","volume":"3","author":"R Kumar","year":"2014","unstructured":"Kumar R, Engwerda C (2014) Vaccines to prevent leishmaniasis. Clin Transl Immunol 3:e13. \nhttps:\/\/doi.org\/10.1038\/cti.2014.4","journal-title":"Clin Transl Immunol"},{"key":"125_CR8","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1002\/1521-4141(2000012)30:12<3498::AID-IMMU3498>3.0.CO;2-6","volume":"30","author":"E von Stebut","year":"2000","unstructured":"von Stebut E, Belkaid Y, Nguyen BV, Cushing M, Sacks DL, Udey MC (2000) Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis. Eur J Immunol 30:3498\u20133506. \nhttps:\/\/doi.org\/10.1002\/1521-4141(2000012)30:12%3c3498:AID-IMMU3498%3e3.0.CO;2-6","journal-title":"Eur J Immunol"},{"key":"125_CR9","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.4049\/jimmunol.170.6.3171","volume":"170","author":"C Berberich","year":"2003","unstructured":"Berberich C, Ramirez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H (2003) Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J Immunol 170:3171\u20133179. \nhttps:\/\/doi.org\/10.4049\/jimmunol.170.6.3171","journal-title":"J Immunol"},{"key":"125_CR10","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.4049\/jimmunol.172.10.6281","volume":"172","author":"JR Ramirez-Pineda","year":"2004","unstructured":"Ramirez-Pineda JR, Frohlich A, Berberich C, Moll H (2004) Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC. J Immunol 172:6281\u20136289. \nhttps:\/\/doi.org\/10.4049\/jimmunol.172.10.6281","journal-title":"J Immunol"},{"key":"125_CR11","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/eji.200636780","volume":"37","author":"KA Remer","year":"2007","unstructured":"Remer KA, Apetrei C, Schwarz T, Linden C, Moll H (2007) Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice. Eur J Immunol 37:2463\u20132473. \nhttps:\/\/doi.org\/10.1002\/eji.200636780","journal-title":"Eur J Immunol"},{"key":"125_CR12","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","volume":"29","author":"M Agallou","year":"2011","unstructured":"Agallou M, Margaroni M, Karagouni E (2011) Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis. Vaccine 29:5053\u20135064. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2011.04.089","journal-title":"Vaccine"},{"key":"125_CR13","doi-asserted-by":"publisher","first-page":"e1003476","DOI":"10.1371\/journal.ppat.1003476","volume":"9","author":"T Schwarz","year":"2013","unstructured":"Schwarz T, Remer KA, Nahrendorf W, Masic A, Siewe L, Muller W, Roers A, Moll H (2013) T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine. PLoS Pathog 9:e1003476. \nhttps:\/\/doi.org\/10.1371\/journal.ppat.1003476","journal-title":"PLoS Pathog"},{"key":"125_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2014.00261","volume":"5","author":"S Majumder","year":"2014","unstructured":"Majumder S, Bhattacharjee A, Paul Chowdhury B, Bhattacharyya Majumdar S, Majumdar S (2014) Antigen-pulsed CpG-ODN-activated dendritic cells induce host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10. Front Immunol 5:261. \nhttps:\/\/doi.org\/10.3389\/fimmu.2014.00261","journal-title":"Front Immunol"},{"key":"125_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0165-2427(03)00071-0","volume":"93","author":"MA Diaz","year":"2003","unstructured":"Diaz MA, Villalobos N, de Aluja A, Rosas G, Gomez-Conde E, Hernandez P, Larralde C, Sciutto E, Fragoso G (2003) Th1 and Th2 indices of the immune response in pigs vaccinated against Taenia solium cysticercosis suggest various host immune strategies against the parasite. Vet Immunol Immunopathol 93:81\u201390. \nhttps:\/\/doi.org\/10.1016\/S0165-2427(03)00071-0","journal-title":"Vet Immunol Immunopathol"},{"key":"125_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1128\/CVI.00106-09","volume":"16","author":"R Segura-Velazquez","year":"2009","unstructured":"Segura-Velazquez R, Fragoso G, Sciutto E, Sarukhan A (2009) Towards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccine. Clin Vaccine Immunol 16:1338\u20131343. \nhttps:\/\/doi.org\/10.1128\/CVI.00106-09","journal-title":"Clin Vaccine Immunol"},{"key":"125_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.vaccine.2005.09.014","volume":"24","author":"R Segura-Velazquez","year":"2006","unstructured":"Segura-Velazquez R, Perez-Torres A, Rosas G, Toledo A, Restelli M, Acosta E, Corral R, Rosetti F, Fragoso G, Grinstein S et al (2006) A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine. Vaccine 24:1073\u20131080. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2005.09.014","journal-title":"Vaccine"},{"key":"125_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1089\/cbr.2012.1438","volume":"28","author":"A Perez-Torres","year":"2013","unstructured":"Perez-Torres A, Vera-Aguilera J, Hernaiz-Leonardo JC, Moreno-Aguilera E, Monteverde-Suarez D, Vera-Aguilera C, Estrada-Barcenas D (2013) The synthetic parasite-derived peptide GK1 increases survival in a preclinical mouse melanoma model. Cancer Biother Radiopharm 28:682\u2013690. \nhttps:\/\/doi.org\/10.1089\/cbr.2012.1438","journal-title":"Cancer Biother Radiopharm"},{"key":"125_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/158980","author":"G Pinon-Zarate","year":"2014","unstructured":"Pinon-Zarate G, Herrera-Enriquez MA, Hernandez-Tellez B, Jarquin-Yanez K, Castell-Rodriguez AE (2014) GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice with melanoma. J Immunol Res. \nhttps:\/\/doi.org\/10.1155\/2014\/158980","journal-title":"J Immunol Res"},{"key":"125_CR20","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1016\/j.vaccine.2017.08.060","volume":"35","author":"D Torres-Garcia","year":"2017","unstructured":"Torres-Garcia D, Perez-Torres A, Manoutcharian K, Orbe U, Servin-Blanco R, Fragoso G, Sciutto E (2017) GK-1 peptide reduces tumor growth, decreases metastatic burden, and increases survival in a murine breast cancer model. Vaccine 35:5653\u20135661. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2017.08.060","journal-title":"Vaccine"},{"key":"125_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","volume":"223","author":"MB Lutz","year":"1999","unstructured":"Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77\u201392. \nhttps:\/\/doi.org\/10.1016\/S0022-1759(98)00204-X","journal-title":"J Immunol Methods"},{"key":"125_CR22","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1084\/jem.180.6.2089","volume":"180","author":"T Zal","year":"1994","unstructured":"Zal T, Volkmann A, Stockinger B (1994) Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 180:2089\u20132099. \nhttps:\/\/doi.org\/10.1084\/jem.180.6.2089","journal-title":"J Exp Med"},{"key":"125_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/expr.1993.1050","volume":"76","author":"PA Bates","year":"1993","unstructured":"Bates PA, Tetley L (1993) Leishmania mexicana: induction of metacyclogenesis by cultivation of promastigotes at acidic pH. Exp Parasitol 76:412\u2013423. \nhttps:\/\/doi.org\/10.1006\/expr.1993.1050","journal-title":"Exp Parasitol"},{"key":"125_CR24","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.4049\/jimmunol.171.7.3705","volume":"171","author":"UM Padigel","year":"2003","unstructured":"Padigel UM, Alexander J, Farrell JP (2003) The role of interleukin-10 in susceptibility of BALB\/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol 171:3705\u20133710. \nhttps:\/\/doi.org\/10.4049\/jimmunol.171.7.3705","journal-title":"J Immunol"},{"key":"125_CR25","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/intimm\/dxh313","volume":"17","author":"LE Rosas","year":"2005","unstructured":"Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR (2005) Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Int Immunol 17:1347\u20131357. \nhttps:\/\/doi.org\/10.1093\/intimm\/dxh313","journal-title":"Int Immunol"},{"key":"125_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16:581\u2013592. \nhttps:\/\/doi.org\/10.1038\/nri.2016.72","journal-title":"Nat Rev Immunol"},{"key":"125_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1078\/1438-4221-00138","volume":"291","author":"H Moll","year":"2001","unstructured":"Moll H, Berberich C (2001) Dendritic cells as vectors for vaccination against infectious diseases. Int J Med Microbiol 291:323\u2013329","journal-title":"Int J Med Microbiol"},{"key":"125_CR28","doi-asserted-by":"publisher","first-page":"e1721","DOI":"10.1371\/journal.pntd.0001721","volume":"6","author":"A Masic","year":"2012","unstructured":"Masic A, Hurdayal R, Nieuwenhuizen NE, Brombacher F, Moll H (2012) Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB\/c mice. PLoS Negl Trop Dis 6:e1721. \nhttps:\/\/doi.org\/10.1371\/journal.pntd.0001721","journal-title":"PLoS Negl Trop Dis"},{"key":"125_CR29","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2012.05.075","volume":"30","author":"M Agallou","year":"2012","unstructured":"Agallou M, Smirlis D, Soteriadou KP, Karagouni E (2012) Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis. Vaccine 30:5086\u20135093. \nhttps:\/\/doi.org\/10.1016\/j.vaccine.2012.05.075","journal-title":"Vaccine"},{"key":"125_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/pim.12097","volume":"36","author":"JC Kling","year":"2014","unstructured":"Kling JC, Darby J, Korner H (2014) CCR30 facilitates the pro-inflammatory function of dendritic cells in experimental leishmaniasis. Parasite Immunol 36:177\u2013185. \nhttps:\/\/doi.org\/10.1111\/pim.12097","journal-title":"Parasite Immunol"},{"key":"125_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1046\/j.1440-1711.2002.01118.x","volume":"80","author":"PD Cravens","year":"2002","unstructured":"Cravens PD, Lipsky PE (2002) Dendritic cells, chemokine receptors and autoimmune inflammatory diseases. Immunol Cell Biol 80:497\u2013505. \nhttps:\/\/doi.org\/10.1046\/j.1440-1711.2002.01118.x","journal-title":"Immunol Cell Biol"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2478\/s11686-019-00125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2478\/s11686-019-00125-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2478\/s11686-019-00125-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T23:05:38Z","timestamp":1601334338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2478\/s11686-019-00125-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.2478\/s11686-019-00125-w","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,30]]},"assertion":[{"value":"4 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}